EGFRBi-armed autologous T cells

· Barbara Ann Karmanos Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFRBi-armed autologous T cells, covering 2016-02-15 to 2016-02-15. Get the full timeline:

Most recent: Clinical Trial Update: EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma [Phase 1, Phase 2]